Delivery Order SPE2DB22D1002-SPE2DB24FKXM2
- Not listed
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The potential value of this order is $5,290.80, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not designated as a set-aside contract. This award is part of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The contract has a potential value of $21,163.20 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for delivering the pharmaceutical products to DLA's...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,054.40 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of medications and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,054.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565562938 - GEL-ONE 30 MG/3 ML SYRINGE 3ML, with a completion date of August 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies essential medical commodities, including prescription drugs, vaccines, and medical supplies, to various federal agencies and healthcare...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for GEL-ONE 30 MG/3 ML SYRINGE 3ML. The potential value of this contract is $1,763.60 and the completion date is March 12, 2024. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense, through indefinite delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The contract has a potential value of $5,290.80 and a completion date of March 19, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $5,290.80 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4564131699 GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products, with a completion date of April 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,527.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563515175 GEL-ONE 30 MG/3 ML SYRINGE 3ML. The $7,054.40 order, with a completion date of February 12, 2024, was placed under an existing contract and does not have a set-aside designation. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that regularly provides...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GEL-ONE 30 MG/3 ML SYRINGE 3ML pharmaceutical products. The $10,581.60 delivery order has a performance period ending on January 17, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, through its corporate office, is an experienced prime contractor providing pharmaceuticals...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKXM2Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. This $5,290.80 contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a completion date of February 26, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. This delivery order is issued under Amerisourcebergen's single award indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver medical products to DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 2/2/24 |